By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Velicept Therapeutics 

101 Lindenwood Drive
Suite 400
Malvern  Pennsylvania  19355  U.S.A.
Phone: 484-318-2988 Fax: 484-324-7949


SEARCH JOBS

Velicept Therapeutics is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead program, solabegron, is a highly differentiated novel compound being investigated for overactive bladder (OAB) and irritable bowel syndrome (IBS). Velicept is a portfolio company of NeXeption.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Dr. James C. Walker

CFO: Doug Gessl

CSO: Dr. Eliot Ohlstein

Head of Project Management: Dr. Jeffrey S. Shaver

Head of Operations: Ray Stevens

Head of Commercial Strategy: Kelly A. Copeland

Head of CMC and QA: Dale Bennyhoff

CLINICAL:

Please click here for Velicept's pipeline.


Key Statistics


Email:
Ownership: Private

Web Site: Velicept Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->